Pioneering AGE research and technology

Diagnoptics is the pioneer in measuring Advanced Glycation End products (AGEs): invisible drivers of aging that impact health and vitality.

About us

Driving innovation in AGE research

At Diagnoptics, we pioneer technologies that make the invisible visible. By measuring Advanced Glycation End products (AGEs), we provide insights that transform how health, vitality and aging are understood worldwide.
DIA_company_mission

Our mission & vision

Empowering better health decisions

We believe that early insights into biological aging can transform healthcare. Our mission is to empower professionals with reliable, science-based tools and our vision is a future where AGE measurement helps people live healthier, longer lives.

Our technology

Bridging science and daily practice

Diagnoptics developed the AGE Reader and AGE Scanner: devices that translate complex science into simple, actionable insights. Both are grounded in decades of research and validated in clinical studies.

Who are we

Pioneers in AGE measurement

Diagnoptics is a spin-off from the University Medical Center Groningen, dedicated to making the invisible impact of AGEs visible. We are a multidisciplinary team of doctors, engineers, and researchers, turning science into practical solutions for health and vitality.

Science & innovation

More than 20 years of AGE research

For over two decades, Diagnoptics has led the way in AGE research and technology. Our devices are backed by hundreds of peer-reviewed studies and international collaborations.

Our history

From university lab to global leader

Founded as a spin-off from the University Medical Center Groningen, Diagnoptics has become the global leader in AGE measurement  setting the standard in non-invasive health assessment.

Today

Diagnoptics continues to lead AGE measurement worldwide, combining innovation with clinical validation to advance healthy aging.

2023

Introduction of the AGE Scanner, developed for therapists and practitioners in lifestyle, nutrition, and wellness.

2020

First explorations beyond clinical settings, preparing for broader applications in lifestyle and preventive health.

2015

We believe early insights into biological aging can improve outcomes and prevent disease. Our mission is to equip professionals with reliable.

2010

AGE Reader adopted in large international cohort studies, strengthening scientific validation worldwide.

2004

Launch of the first AGE Reader, making non-invasive AGE measurement available in clinical research.

2003

Diagnoptics is founded as a spin-off from the University Medical Center Groningen, focused on AGE research and technology.

Careers

We are not hiring right now,
but always interested in talent

At the moment we don’t have open positions. Still, we’re always interested in meeting talented
professionals who share our mission to pioneer AGE research and technology. If you would like
to be considered for future opportunities, feel free to reach out.

Open applications

Send us your CV and motivation. We’ll keep your profile in mind for upcoming roles.

Strategic partnerships

Collaboration drives progress

We work closely with leading universities, hospitals and research institutes worldwide. These partnerships validate our technology, expand applications, and ensure that AGE measurement continues to advance clinical and practical use.

Interested in more information?

Contact us

Whether you’re interested in a product demo, research evidence or collaboration, our team is ready to assist you.

Open applicAtions

Fill out the form below, and we will be in touch shortly.

Download case study

Please leave your name, organization and email to download this AGE Reader case study.